Medicilon in one place
Dive Deeper
Corporate News
- Corporate News
China’s First mRNA-Based In Vivo CAR-T Candidate! Medicilon Supports Regenelead RGL-208 IND Approval
- Corporate News
Medicilon and China Pharmaceutical University Forge Industry-University Research Collaboration on Novel Conjugate Therapeutics to Empower New Drug Innovation
- Corporate News
7th Anniversary Q&A 7: Seven Years Listed, Honors Without Number: Why Does Medicilon Keep the Trust of the Industry and Its Clients?
- Corporate News
7th Anniversary Q&A 6: One IND Approval Every Four Days on Average: How Does Medicilon Balance R&D Speed and Quality?
- Corporate News
Medicilon Debuts at CIIE, Connecting the World
- Corporate News
Nonclinical Toxicology Services (GLP and non-GLP)
Events
- Events
Nov. 16(Mon.) - 19 (Thu.), 2026. Venue: Tsukuba International Congress Center, Tsukuba, Japan.
JSSX 2026
- Events
Oct. 15 (Thu.) - 16 (Fri.), 2026. Venue, Alpensia Resort, Pyeongchang, South Korea.
50th Korean Society of Nonclinical Studies (KSNS)
- Events
Oct. 7 (Wed.) - 9 (Fri.), 2026 10:00-17:00. Venue, PACIFICO Yokohama.
BIOJAPAN 2026
- Events
Basel, Switzerland from September 6-10, 2026
EFMC-ISMC 2026
- Events
Date: August 27-28, 2026
Venue:The Westin Seoul Parnas, South Korea - Medicilon Booth #6
Venue:The Westin Seoul Parnas, South Korea - Medicilon Booth #6
4th SMC and AimedBio ADC Conference
- Events
Date: August 23-27, 2026
Venue: McCormick Place Convention Center, Chicago, IL - Medicilon Booth #400
Venue: McCormick Place Convention Center, Chicago, IL - Medicilon Booth #400
ACS Fall 2026
Medicilon Academy
- Medicilon Academy
【Case Study】New Approach Methods NAMs
- Medicilon Academy
【Case Study】Route, Solid-State, and Impurity Optimization (Small-Molecule API)
- Medicilon Academy
【Case Study】IND Completion in 12 Months (Small-Molecule NCE)
- Medicilon Academy
Boston Non-Tumor Models Innovation
- Medicilon Academy
【White Paper】Navigating the DMPK Gauntlet: A Strategic Analysis of the Interconnected Challenges Shaping the Future of Drug Development
- Medicilon Academy
【White Paper】Patient-Derived Xenograft Organoids: Advancements and Applications in Precision Oncology
Digital Materials
- Digital Materials
Medicilon TPD & RIPTAC R&D Service Platform
- Digital Materials
Medicilon Nonclinical Toxicology Services
- Digital Materials
Medicilon NAMs Drug Service Platform
- Digital Materials
Medicilon – From Target to IND, Accelerating New Drug R&D
- Digital Materials
Revolutionizing Targeted Therapies with Advanced AOC Solutions
- Digital Materials
